Stem Cell Research & TherapyImmunologyPeer-reviewed journal article
Uncovering the bequeathing potential of Apoptotic Mesenchymal Stem Cells via small Extracellular Vesicles for its enhanced immunomodulatory ability
Meenakshi MendirattaiD, Mohini MendirattaiD, Yashvi SharmaiD, Ranjit Kumar SahooiD, Neena Malhotra, Sujata MohantyiD
Abstract
Small Extracellular Vesicles (sEVs) derived from Mesenchymal Stem Cells (MSCs) have emerged as a promising avenue for cell-free therapeutics in regenerative medicine. These vesicles, endowed with regenerative cargo inherited from their parent cells, have attracted attention for their role in immunomodulation and ROS alleviation. Notably, the deliberate induction of apoptosis in MSCs prior to Extracellular Vesicles (EVs) isolation has been identified as a strategy to augment the regenerative capabilities of MSCs-EVs, as certain reports have suggested that MSCs undergo apoptosis to exert their therapeutic effect post-transplantation. Moreover, selecting an optimal tissue source for deriving MSC-sEVs is equally crucial to ensure consistent and improved clinical outcomes. Multiple attributes of MSCs like their antioxidant, Immunomodulatory & regenerative properties make them particularly appealing for clinical studies, wherein mechanisms such as paracrine secretions and efferocytosis play pivotal roles. This investigation meticulously explores the comparative immunomodulatory & antioxidant capabilities of Apoptotic sEVs (Apo-sEVs) with Viable sEVs (V-sEVs) obtained from both Bone Marrow (BM) and Whartons Jelly (WJ)-derived MSCs, using an in vitro liver injury model. The findings from the present study contribute valuable insights into the comparative efficacy of Apo-sEVs and V-sEVs. This will aid in addressing a critical gap in understanding the role of apoptosis in enhancing the reparative capability of MSCs-sEVs. It also aims to shed light on the optimal source of MSCs for generating Apo-sEVs in translational applications. GRAPHICAL ABSTARCT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/590581v1_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@1392183org.highwire.dtl.DTLVardef@1c72d6borg.highwire.dtl.DTLVardef@176ee90org.highwire.dtl.DTLVardef@128559e_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 5
- FWCI
- 1.20
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Extracellular Vesicle-Enriched Secretome from Mesenchymal Stromal Cells Protects Against Chemically, Particulate-, and Ischemia-Induced Innate-Immunity Induced Inflammation
Kyong‐Su Park, Negar Ordouzadeh, … Massimo Dominici·bioRxiv·Apr 13, 2026
- Investigation of immune response to Mesenchymal Stromal Cell-derived Extracellular Vesicles in the cancer setting
Katie Gilligan, Oliver Treacy, … Róisín M. Dwyer·bioRxiv·Jan 28, 2025
- Priming of MSCs with inflammation-relevant signals affects extracellular vesicle biogenesis, surface markers, and modulation of T cell subsets
S. H. Andrews, T. Maughon, … S. L. Stice·bioRxiv·Apr 30, 2020
- Surface marker expression in small and medium/large mesenchymal stromal cell-derived extracellular vesicles in naive or apoptotic condition using orthogonal techniques
R. Skovronova, C. Grange, … B. Bussolati·bioRxiv·Sep 16, 2021
- Exogenous Sphingomyelinase Mediates MSC-derived EV Biogenesis and Enhances Potency via Repackaging of Molecular Cargo
Daniel C. Shah, S’Dravious A. DeVeaux, … Edward A. Botchwey·iSciencePeer-reviewed·Feb 11, 2026
- Small Extracellular Vesicles from Human Bone Marrow Mesenchymal Stromal Cells enhance migration and regulate gene expression of reparative mechanisms in human dermal fibroblasts
Rui Lei, Tamiris Borges da Silva, … Hua Ye·Scientific ReportsPeer-reviewed·Jun 3, 2025